19937 results for «»
19937 results
Khaled Buresly
Kuwait, Kuwait
Ruth Campbell
Galway, Ireland
Omer Elamin
Jeddah, Saudi Arabia
Ahmed Emam
Kuwait, Kuwait
Erwing Enrique Gonzalez Gurrola
Mexico
Hatem Hilal
Egypt
Salman Ishaque
Karachi, Pakistan
Huda Ismail
Riyadh, Saudi Arabia
Mahmoud Khalil
KAFRELSHIKH, Egypt
Introducing #PCRLV 2022 Ambassadors!
Davide Giovannini
Cotignola, Italy
Michael Young
New Hampshire, United States of America
A patient with ACS – how should I treat the left main?
31 Oct 2022
Take a virtual trip to Chennai, India for this first PCR Webinar on the Road.
How and when should I consider Drug Coated Balloons to treat de novo lesions?
31 Oct 2022
Discover the replay of this PCR Webinar on Drug Coated Balloons with F. Ribichini, F. Manterola and D. Mylotte.
#1 - How should I treat a patient with in-stent restenosis ?
31 Oct 2022
Discover the replay of this PCR Webinar on drug-coated-balloons with F. Ribichini, B. Scheller and A. G. Zaman
Clement Tan
Hamilton, New Zealand
Hari Sritharan
NSW, Australia
Ultrasound supported thrombolysis: a live-saving procedure in massive saddle pulmonary embolism
15 Dec 2022 – From GulfPCR-GIM 2022
Watch this GulfPCR-GIM 2022 session to learn how and why minimally invasive catheter directed thrombolytic therapy assisted by ultrasound can be effective and safe, even in massive pulmonary embolism with compromised RV function.
Left main multivessel disease and other coronary interventions
15 Dec 2022 – From GulfPCR-GIM 2022
This GulfPCR-GIM 2022 session will allow you to study a rare case of coronary artery dissection due to blunt chest trauma leading to myocardial infarction, the evolution from LAD to LMS stenting, the use of a mini-crush for a complex left main bifurcation, and much more!
Cracking calcium: intravascular lithotripsy’s unique mode of action in treating calcified lesions – What's the evidence?
14 Dec 2022 – From GulfPCR-GIM 2022
Watch this GulfPCR-GIM 2022 session to understand the unique mechanism of action of IVL, the use of intravascular imaging in calcium identification, the gender gap, disrupted CAD trials, and the evolution of treatment of calcified lesions together with the role of IVL.
